Catheter ablation of atrial fibrillation: For whom and how?

Angiology

Volumn 59, Issue 2_suppl, 2008, Pages 103S-106S

  Katritsis, Demosthenes G ^a  

^a Athens Euroclinic   (Greece)

Author keywords

atrial fibrillation; catheter ablation; pulmonary vein isolation

Indexed keywords

ATRIAL FIBRILLATION; AUTONOMIC DENERVATION; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONFERENCE PAPER; ELECTROGRAPHY; ESOPHAGUS FISTULA; HEART LEFT VENTRICLE FAILURE; OUTCOME ASSESSMENT; PAROXYSMAL ATRIAL FIBRILLATION; PULMONARY VEIN ISOLATION; QUALITY OF LIFE; HEART ATRIUM FIBRILLATION; HUMAN; METHODOLOGY; PATIENT SELECTION; REVIEW;

ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; PATIENT SELECTION;

EID: 53049095601     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319708318581     Document Type: Conference Paper

References (32)

1. Katritsis DG, Camm AJ Catheter ablation of atrial fibrillation: do we know what we are doing? Europace. 2007; 9: 1002-1005.
2. Cappato R., Calkins H., Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005; 111: 1100-1105.
3. Katritsis DG, Wood MA, Giazitzoglou E., et al. Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation. Europace. In press.
4. Pappone C., Augello G., Sala S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF (Ablation for Paroxysmal Atrial Fibrillation) study. J Am Coll Cardiol. 2006; 48: 2340-2347.
5. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005; 293: 2634-2640.
6. Oral H., Pappone C., Chugh A., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006; 354: 934-941.
7. Takahashi Y., O'Neill MD, Hocini M., et al. Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol. 2008; 51: 1003-1010.
8. Hsu LF, Jais P., Sanders P., et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004; 351: 2373-2383.
9. Gerstenfeld EP, Callans D., Dixit S., et al. Characteristics of patients undergoing atrial fibrillation ablation: trends over a seven-year period 1999-2005. J Cardiovasc Electrophysiol. 2007; 18: 23-28.
10. Sauer WH, McKernan ML, Lin D., Gerstenfeld EP, Callans DJ, Marchlinski FE Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm. 2006; 3: 1024-1028.
11. Stabile G., Turco P., La Rocca V., Nocerino P., Stabile E., De Simone A. Is pulmonary vein isolation necessary for curing atrial fibrillation? Circulation. 2003; 108: 657-660.
12. Katritsis D., Ellenbogen KA, Camm AJ Recurrence of pulmonary vein-left atrium conduction following successful disconnection in asymptomatic patients. Europace. 2004; 6: 425-432.
13. Hocini M., Sanders P., Jais P., et al. Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2004; 15: 1467-1471.
14. Lemola K., Oral H., Chugh A., et al. Pulmonary vein isolation as an end point for left atrial circumferential ablation of atrial fibrillation. J Am Coll Cardiol. 2005; 46: 1060-1066.
15. Kottkamp H., Tanner H., Kobza R., et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure. ? J Am Coll Cardiol. 2004; 44: 869-877.
16. Oral H., Chugh A., Good E., et al. Randomized comparison of encircling and nonencircling left atrial ablation for chronic atrial fibrillation. Heart Rhythm. 2005; 2: 1165-1172.
17. Mesas CE, Pappone C., Lang CC, et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J Am Coll Cardiol. 2004; 44: 1071-1079.
18. Katritsis DG, Giazitzoglou E., Wood MA, Shepard RK, Parvez B., Ellenbogen KA Inducible supraventricular tachycardias in patients referred for catheter ablation of atrial fibrillation. Europace. 2007; 9: 785-789.
19. Nademanee K., McKenzie J., Kosar E., et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004; 43: 2044-2053.
20. Oral H., Chugh A., Good E., et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation. 2007; 115: 2606-2612.
21. Katritsis D., Ioannidis J., Anagnostopoulos CE, et al. Catheter ablation of extracardiac and intracardiac components of ligament of Marshall tissue: a novel approach for the treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2001; 12: 750-758.
22. Schauerte P., Scherlag BJ, Pitha J., et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation. 2000; 102: 2774-2780.
23. Lemola K., Chartier D., Yeh YH, et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Circulation. 2008; 117: 470-477.
24. Oh S., Zhang Y., Bibevski S., Marrouche NF, Natale A., Mazgalev TN Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm. 2006; 3: 701-708.
25. Hirose M., Leatmanoratn Z., Laurita KR, Carlson MD Partial vagal denervation increases vulnerability to vagally induced atrial fibrillation. J Cardiovasc Electrophysiol. 2002; 13: 1272-1279.
26. Katritsis DG, Giazitzoglou E., Sougiannis D., et al. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol. In press.
27. Oral H., Chugh A., Lemola K., et al. Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study. Circulation. 2004; 110: 2797-2801.
28. Katritsis D., Giazitzoglou E., Korovesis S., Kourlaba G., Voridis E., Camm AJ Staged circumferential and ostial pulmonary vein ablation for the treatment of paroxysmal atrial fibrillation. PACE. 2007; 30: 102-108.
29. Katritsis DG, Ellenbogen KA, Giazitzoglou E., et al. Clinical outcome of left atrial ablation for paroxysmal atrial fibrillation is related to the extent of radiofrequency ablation. J Interv Cardiac Electrophysiol. In press.
30. Packer DL, Keelan P., Munger TM, et al. Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation. 2005; 111: 546-554.
31. Pappone C., Oral H., Santinelli V., et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation. 2004; 109: 2724-2726.
32. Reynolds MR, Fishel RS, Brown PP, et al. Catheter ablation for atrial fibrillation: trends in patient profiles, clinical outcomes and costs in community hospitals since 2003. Presented at the Heart Rhythm 2007, Abstracts of the 28th Annual Scientific Sessions of the Heart Rhythm Society; May 11, 2007; Denver, CO. Abstract AB30-4.